In Uganda, a study by Nakandi et al. in 2013 revealed that only 22.9% of Ugandan men considered getting a serum PSA test and only 3.5% had ever undergone a serum PSA test for prostate cancer screening [14]. This evidence concerns the gene KLK3 and prostate carcinoma.